NEW YORK (GenomeWeb) – Patients who receive genetic tests for cancer risks should be able to trust that the labs conducting their tests behave ethically, and that the genetic data these labs generate will be made publicly available, three genetics researchers said in a commentary published this month in Evidence-Based Oncology.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: factors influencing retrotransposon integration sites, and more.

A bioethicist argues for the responsible use of germline gene editing.

Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.

Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.